Notice of Waiver of the Referral Requirement for TRICARE Prime Enrollees, Not Including Active Duty Service Members (ADSMs), So They May Receive COVID-19 Vaccines From Any TRICARE-Authorized Non-Network Provider Without Incurring Point-of-Service Charges Where Applicable, 10942-10943 [2021-03667]
Download as PDF
<![CDATA[
10942
Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices
purpose of the proposed action is
threefold: (1) Address the needs of
fishing communities, consistent with
NOAA’s mandate through the
Saltonstall-Kennedy Act; (2) ensure
NOAA continues to meet the
requirements of the Saltonstall-Kennedy
Act; and (3) assist NOAA in meeting its
mission, ‘‘To understand and predict
changes in climate, weather, oceans,
and coasts, to share that knowledge and
information with others, and to
conserve and manage coastal and
marine ecosystems and resources’’. The
Proposed Action is needed to address
the needs of fishing communities by
building and maintaining sustainable
fisheries, optimizing economic benefits,
and increasing other opportunities to
keep working waterfronts viable.
Types of projects funded by the S–K
Program include, but are not limited to,
promotion and marketing; aquaculture;
gear testing; bycatch reduction
engineering; research and monitoring;
stock assessments; data collection;
socioeconomic research; climate change;
and workshops and conferences.
Alternatives
NOAA is preliminarily preparing to
analyze two program-level alternatives:
(1) A No Action Alternative, and (2) the
proposed action, which NOAA is
referring to as the Promotion, Marketing,
Research and Development Alternative.
Under the No Action Alternative, the S–
K Program would not fund projects that
address the needs of fishing
communities, optimize economic
benefits by building and maintaining
sustainable fisheries, and increase other
opportunities to keep working
waterfronts viable. Although the No
Action Alternative would not meet the
purpose and need, it serves as a baseline
against which the impacts of the
Promotion, Marketing, Research and
Development Alternative will be
compared and contrasted.
Implementation of the Promotion,
Marketing, Research and Development
Alternative, will allow for funding
actions through federal financial
assistance for all possible types of
projects that meet the needs of U.S.
fishing communities, consistent with
the scope of the S–K Program. This
alternative would provide the S–K
Program with flexibility in choosing
priorities each year while also
considering the funding environment.
We invite public comments on the
proposed scope of the alternatives and
are particularly interested in comments
regarding potential additional
alternatives.
VerDate Sep<11>2014
18:36 Feb 22, 2021
Jkt 253001
Scoping Process
This notice initiates a public scoping
period for the PEIS. Please review the
information in this notice and
additional information about the S–K
Program, located on the NOAA S–K
Program website (see the FOR FURTHER
INFORMATION CONTACT section above).
NOAA is particularly interested in
receiving comments regarding
biological, cultural, or ecological issues
that the analysis should address. We
also encourage comments that assist us
in further delineating the proposed
project, its potential to affect the human
environment, means for avoiding,
minimizing, or mitigating those effects,
the preliminary range of alternatives,
any additional reasonable alternatives
that should be considered, and other
issues of public concern. To promote
informed decision-making, we
especially encourage commenters to
submit any scientific data, studies, or
research that you feel is relevant to the
analysis.
To facilitate the public and agency
involvement in the PEIS process, NOAA
will hold three public-scoping meetings
during the scoping period. The meetings
will be virtual in format. The scoping
meetings will solicit input from the
public and interested public agencies
regarding the scope of environmental
impacts to be addressed in the draft
PEIS. Three virtual public scoping
meetings (in webinar format only) will
be held in each of three regions, as
follows:
• Eastern and Gulf of Mexico Region
(includes Atlantic States, Gulf of
Mexico States, U.S. Virgin Islands,
and Puerto Rico)—March 9, 2021
Æ 12:00 p.m.–3:00 p.m. Central
Standard Time (CST)
Æ 1:00 p.m.– 4:00 p.m. Eastern
Standard Time (EST)
• Western Region (includes Pacific
States, Idaho, Alaska)—March 10,
2021
Æ 10:00 a.m.–1:00 p.m. Pacific
Standard Time (PST)
Æ 9:00 a.m.–12:00 p.m. Alaska
Standard Time (AKST)
• Western Pacific Region (includes
Hawaii and Pacific Territories)—
March 11, 2021, March 12, 2021
Æ March 11, 2021, 2:00 p.m.–5:00
p.m. Hawaii-Aleutian Standard
Time (HST)
Æ March 12, 2021, 10:00 a.m.–1:00
p.m. Chamorro Standard Time
(CHST)
Use the webinar link and dial-in
information below to join one of the
public scoping meetings:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Webinar Link: https://
kearnsandwest.webex.com/meet/
webexalias3
Access Code: 146 622 5582
Dial-in Information: 1–844–621–3956
(U.S. Toll Free) | +1–415–655–0001
(U.S. Toll)
Participants are encouraged to
download the Webex Meetings app
ahead of the meetings, using this link:
https://www.webex.com/
downloads.html. Then use the meeting
link above to join a public scoping
meeting at the appropriate time. You
may also participate by phone toll-free
by calling 1–844–621–3956, then
entering the Access Code above when
prompted.
After the comment period closes,
NOAA will review and consider all
comments received during the comment
period and any other relevant
information when developing the draft
PEIS. Upon completion of the draft
PEIS, a document announcing its
availability and an opportunity to
comment will be published in the
Federal Register.
Authority: This PEIS will be prepared
under the authority of, and in accordance
with, the requirements of NEPA,
implementing regulations published by the
Council on Environmental Quality (40 CFR
1500–1508), other applicable regulations, and
NOAA’s policies and procedures for
compliance with those regulations.
Dated: February 16, 2021.
Daniel A. Namur,
Director of the NMFS Financial Assistance
Division, National Marine Fisheries Service.
[FR Doc. 2021–03626 Filed 2–22–21; 8:45 am]
BILLING CODE 3510–22–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Waiver of the Referral
Requirement for TRICARE Prime
Enrollees, Not Including Active Duty
Service Members (ADSMs), So They
May Receive COVID–19 Vaccines From
Any TRICARE-Authorized Non-Network
Provider Without Incurring Point-ofService Charges Where Applicable
Office of the Secretary,
Department of Defense (DoD).
ACTION: Notice of waiver.
AGENCY:
This notice is to advise
TRICARE Prime enrollees, not including
ADSMs, of a waiver to the referral
requirement so they may receive
COVID–19 vaccines, a clinical
preventive service, from any TRICARE
authorized non-network provider
SUMMARY:
E:\FR\FM\23FEN1.SGM
23FEN1
Federal Register / Vol. 86, No. 34 / Tuesday, February 23, 2021 / Notices
without incurring POS charges where
applicable.
This waiver is effective on
December 13, 2020.
ADDRESSES: Defense Health Agency
(DHA), 16401 East Centretech Parkway,
Aurora, CO 80011–9066.
FOR FURTHER INFORMATION CONTACT:
Valerie Palmer, Defense Health Agency,
303–676–3557, valerie.a.palmer3.civ@
mail.mil.
DATES:
In
December 2019, an outbreak of
respiratory disease caused by a novel
coronavirus was detected in Wuhan
City, Hubei Province, China. The virus
has been named SARS–CoV–2 and the
disease it causes has been named
COVID–19. This virus has spread
rapidly throughout the United States
(U.S.) and around the world.
On January 31, 2020, the Secretary of
the Department of Health and Human
Services, Alex Azar, declared a public
health emergency pursuant to Section
319 of the Public Health Service Act for
the entire U.S. to aid in the Nation’s
health care community response to
COVID–19, retroactive to January 27,
2020. On March 13, 2020, President
Donald Trump declared that the
COVID–19 outbreak in the U.S.
constituted a national emergency,
beginning March 1, 2020.
Thus far, two vaccines have been
approved by the Food and Drug
Administration (FDA) for the prevention
of COVID–19 in the U.S. On December
11, 2020, the FDA issued an Emergency
Use Authorization (EUA) for the PfizerBioNTech COVID–19 vaccine (Pfizer,
Inc.; Philadelphia, Pennsylvania).
Vaccination with the Pfizer-BioNTech
COVID–19 vaccine consists of two doses
administered intramuscularly, three
weeks apart. On December 12, 2020, the
Advisory Committee on Immunization
Practices (ACIP) issued an interim
recommendation for use of the PfizerBioNTech COVID–19 vaccine in persons
aged 16 years and older for the
prevention of COVID–19. The
recommendation was published in an
early release of the Morbidity and
Mortality Weekly Report (MMWR) on
December 13, 2020; thus, this vaccine
may now be covered by TRICARE.
On December 18, 2020, the FDA
issued an EUA for the Moderna COVID–
19 (mRNA–1273) vaccine (ModernaTX,
Inc; Cambridge, Massachusetts).
Vaccination with the Moderna COVID–
19 vaccine consists of two doses
administered intramuscularly, four
weeks apart. On December 19, 2020, the
ACIP issued an interim
recommendation for use of the Moderna
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:36 Feb 22, 2021
Jkt 253001
COVID–19 vaccine in persons aged 18
years and older for the prevention of
COVID–19. The recommendation was
published in an early release of the
MMWR on December 20, 2020; thus,
this vaccine may also be covered by
TRICARE.
Except under very special
circumstances, a beneficiary enrolled in
TRICARE Prime is required to obtain a
referral for care through a designated
primary care manager (or other
authorized care coordinator) prior to
obtaining care under the TRICARE
program, otherwise POS charges apply.
The DHA believes the widespread need
for COVID–19 vaccines and the fact that
supply of these vaccines may be limited
is a special circumstance necessitating
the waiver of the referral requirement
for TRICARE Prime enrollees so they
may receive a COVID–19 vaccine, a
clinical preventive service, from any
TRICARE authorized non-network
provider without incurring POS charges
where applicable. This waiver will
apply for the period of the U.S.
President’s declaration of the COVID–19
national emergency.
Dated: January 25, 2021.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2021–03667 Filed 2–22–21; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF EDUCATION
[Docket No.: ED–2021–SCC–0027]
Agency Information Collection
Activities; Comment Request;
Reaffirmation Agreement
Federal Student Aid,
Department of Education (ED).
ACTION: Notice.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995, ED is
proposing an extension without change
of a currently approved collection.
DATES: Interested persons are invited to
submit comments on or before April 26,
2021.
ADDRESSES: To access and review all the
documents related to the information
collection listed in this notice, please
use https://www.regulations.gov by
searching the Docket ID number ED–
2021–SCC–0027. Comments submitted
in response to this notice should be
submitted electronically through the
Federal eRulemaking Portal at https://
www.regulations.gov by selecting the
Docket ID number or via postal mail,
commercial delivery, or hand delivery.
If the regulations.gov site is not
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
10943
available to the public for any reason,
ED will temporarily accept comments at
ICDocketMgr@ed.gov. Please include the
docket ID number and the title of the
information collection request when
requesting documents or submitting
comments. Please note that comments
submitted by fax or email and those
submitted after the comment period will
not be accepted. Written requests for
information or comments submitted by
postal mail or delivery should be
addressed to the PRA Coordinator of the
Strategic Collections and Clearance
Governance and Strategy Division, U.S.
Department of Education, 400 Maryland
Ave. SW, LBJ, Room 6W208D,
Washington, DC 20202–8240.
FOR FURTHER INFORMATION CONTACT: For
specific questions related to collection
activities, please contact Beth
Grebeldinger, 202–377–4018.
SUPPLEMENTARY INFORMATION: The
Department of Education (ED), in
accordance with the Paperwork
Reduction Act of 1995 (PRA) (44 U.S.C.
3506(c)(2)(A)), provides the general
public and Federal agencies with an
opportunity to comment on proposed,
revised, and continuing collections of
information. This helps the Department
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand the
Department’s information collection
requirements and provide the requested
data in the desired format. ED is
soliciting comments on the proposed
information collection request (ICR) that
is described below. The Department of
Education is especially interested in
public comment addressing the
following issues: (1) Is this collection
necessary to the proper functions of the
Department; (2) will this information be
processed and used in a timely manner;
(3) is the estimate of burden accurate;
(4) how might the Department enhance
the quality, utility, and clarity of the
information to be collected; and (5) how
might the Department minimize the
burden of this collection on the
respondents, including through the use
of information technology. Please note
that written comments received in
response to this notice will be
considered public records.
Title of Collection: Reaffirmation
Agreement.
OMB Control Number: 1845–0133.
Type of Review: An extension without
change of a currently approved
collection.
Respondents/Affected Public:
Individuals and Households; Private
Sector; State, Local, and Tribal
Governments.
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 86, Number 34 (Tuesday, February 23, 2021)]
[Notices]
[Pages 10942-10943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03667]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Waiver of the Referral Requirement for TRICARE Prime
Enrollees, Not Including Active Duty Service Members (ADSMs), So They
May Receive COVID-19 Vaccines From Any TRICARE-Authorized Non-Network
Provider Without Incurring Point-of-Service Charges Where Applicable
AGENCY: Office of the Secretary, Department of Defense (DoD).
ACTION: Notice of waiver.
-----------------------------------------------------------------------
SUMMARY: This notice is to advise TRICARE Prime enrollees, not
including ADSMs, of a waiver to the referral requirement so they may
receive COVID-19 vaccines, a clinical preventive service, from any
TRICARE authorized non-network provider
[[Page 10943]]
without incurring POS charges where applicable.
DATES: This waiver is effective on December 13, 2020.
ADDRESSES: Defense Health Agency (DHA), 16401 East Centretech Parkway,
Aurora, CO 80011-9066.
FOR FURTHER INFORMATION CONTACT: Valerie Palmer, Defense Health Agency,
303-676-3557, [email protected].
SUPPLEMENTARY INFORMATION: In December 2019, an outbreak of respiratory
disease caused by a novel coronavirus was detected in Wuhan City, Hubei
Province, China. The virus has been named SARS-CoV-2 and the disease it
causes has been named COVID-19. This virus has spread rapidly
throughout the United States (U.S.) and around the world.
On January 31, 2020, the Secretary of the Department of Health and
Human Services, Alex Azar, declared a public health emergency pursuant
to Section 319 of the Public Health Service Act for the entire U.S. to
aid in the Nation's health care community response to COVID-19,
retroactive to January 27, 2020. On March 13, 2020, President Donald
Trump declared that the COVID-19 outbreak in the U.S. constituted a
national emergency, beginning March 1, 2020.
Thus far, two vaccines have been approved by the Food and Drug
Administration (FDA) for the prevention of COVID-19 in the U.S. On
December 11, 2020, the FDA issued an Emergency Use Authorization (EUA)
for the Pfizer-BioNTech COVID-19 vaccine (Pfizer, Inc.; Philadelphia,
Pennsylvania). Vaccination with the Pfizer-BioNTech COVID-19 vaccine
consists of two doses administered intramuscularly, three weeks apart.
On December 12, 2020, the Advisory Committee on Immunization Practices
(ACIP) issued an interim recommendation for use of the Pfizer-BioNTech
COVID-19 vaccine in persons aged 16 years and older for the prevention
of COVID-19. The recommendation was published in an early release of
the Morbidity and Mortality Weekly Report (MMWR) on December 13, 2020;
thus, this vaccine may now be covered by TRICARE.
On December 18, 2020, the FDA issued an EUA for the Moderna COVID-
19 (mRNA-1273) vaccine (ModernaTX, Inc; Cambridge, Massachusetts).
Vaccination with the Moderna COVID-19 vaccine consists of two doses
administered intramuscularly, four weeks apart. On December 19, 2020,
the ACIP issued an interim recommendation for use of the Moderna COVID-
19 vaccine in persons aged 18 years and older for the prevention of
COVID-19. The recommendation was published in an early release of the
MMWR on December 20, 2020; thus, this vaccine may also be covered by
TRICARE.
Except under very special circumstances, a beneficiary enrolled in
TRICARE Prime is required to obtain a referral for care through a
designated primary care manager (or other authorized care coordinator)
prior to obtaining care under the TRICARE program, otherwise POS
charges apply. The DHA believes the widespread need for COVID-19
vaccines and the fact that supply of these vaccines may be limited is a
special circumstance necessitating the waiver of the referral
requirement for TRICARE Prime enrollees so they may receive a COVID-19
vaccine, a clinical preventive service, from any TRICARE authorized
non-network provider without incurring POS charges where applicable.
This waiver will apply for the period of the U.S. President's
declaration of the COVID-19 national emergency.
Dated: January 25, 2021.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2021-03667 Filed 2-22-21; 8:45 am]
BILLING CODE 5001-06-P
